Fasting Glucose vs. Continuous Glucose Data: What Your CGM Can and Can't Tell a Provider

You've been watching your glucose curves for months, correlating them with meals, sleep, and training. Here's the honest engineering answer to a question you've probably already asked: what does that continuous stream actually add to a clinical picture, and where does it quietly mislead you?

Three instruments, three different questions

Fasting glucose, HbA1c, and a CGM are not three ways of measuring the same thing. They answer different questions at different time resolutions, and a provider reads them together for exactly that reason.

Fasting plasma glucose is a single point sample after ~8 hours without food. It's the anchor most diagnostic thresholds are built on: the American Diabetes Association places normal fasting glucose below 100 mg/dL, prediabetes at 100–125 mg/dL, and diabetes at 126 mg/dL or higher on a repeat draw ^[1]. It's cheap, standardized, and venous — but it's one moment, sensitive to the prior night's sleep, stress, and even a poorly timed dawn phenomenon.

HbA1c integrates roughly 2–3 months of exposure by measuring glycated hemoglobin. The ADA thresholds: normal below 5.7%, prediabetes 5.7–6.4%, diabetes 6.5% or higher ^[1]. Because it depends on red-blood-cell lifespan, A1c can read falsely low or high in anemia, recent blood loss, hemoglobin variants, or altered erythrocyte turnover — a real blind spot the NIDDK flags explicitly ^[2]. For a lean, athletic person, that's not trivia: intense endurance training can shift RBC dynamics.

A CGM samples interstitial glucose every few minutes, producing the curves you already love. It's the only one of the three that shows *variability* and *postprandial excursions* — the shape of the response, not just the level.

Where the CGM genuinely adds signal

The continuous stream reveals things a fasting draw structurally cannot. Two metrics matter most to a provider reading longevity data.

Time in range (TIR) — the percentage of readings within a target band — and glycemic variability, usually expressed as the coefficient of variation (CV). An international consensus panel proposed standardized CGM targets and defined stable glucose as a CV at or below 36% ^[3]. That variability lens is exactly what a single fasting number erases.

CGM also catches *pattern* information: a reproducible post-meal spike to a specific food, nocturnal drift, or a morning rise that a 7 a.m. draw would capture as a single confusing data point. For someone iterating on diet and training, that's the highest-value output — not the absolute numbers, but the reproducible responses.

Where the CGM misleads

This is the part optimization forums underweight.

Interstitial ≠ plasma, and there's a lag. CGMs measure interstitial fluid, which trails blood glucose — typically on the order of several minutes, and more during rapid changes like a sharp post-meal rise or hard interval work. So a CGM-reported "spike" and a simultaneous fingerstick can legitimately disagree.

Accuracy is good, not laboratory-grade. Consumer and clinical CGMs report accuracy as MARD (mean absolute relative difference) against a reference. Modern sensors land in the single-digit-percent range, but that's an average — individual readings, especially at the low and high extremes, can be off by more. The FDA has cleared integrated CGMs (iCGM) with defined accuracy criteria precisely because performance varies ^[4].

Newer non-prescription wellness CGMs are not diagnostic devices. In 2024 the FDA cleared over-the-counter CGMs for general wellness use in people not on insulin — useful, but the agency and reviewers have cautioned that these are not intended to diagnose disease and can display readings that differ from blood values ^[4]. A curve is a hypothesis generator, not a diagnosis.

The practical rule a provider applies: use the CGM for trends and reproducible patterns; use the venous draw for thresholds and decisions.

The blood markers a CGM will never replace

Here's what actually matters for a longevity plan built around metabolic health — none of which a glucose sensor sees.

• Fasting insulin and HOMA-IR. Glucose can look normal for years while insulin climbs to keep it there. A fasting insulin plus glucose lets a provider estimate insulin resistance. This is often the earliest movable signal in a lean, active person whose glucose still reads "fine."
• Lipid panel with ApoB. ApoB counts atherogenic particles directly and is endorsed by major cardiology guidance as a more precise risk marker than LDL-C alone in many contexts ^[5].
• hs-CRP for low-grade inflammation.
• Comprehensive metabolic panel — liver and kidney function — which matters for anyone considering any prescribed protocol.
• A1c or an alternative like fructosamine when RBC turnover makes A1c unreliable ^[2].

CGM data is a complement to this panel, not a substitute. The most useful thing you can bring to a provider is your CGM export *plus* a recent fasting draw — the two together resolve each other's blind spots.

Bringing it into a physician relationship

The workflow that respects your data looks like this: a fasting venous panel establishes the anchors (glucose, A1c, insulin, lipids/ApoB, CMP, hs-CRP); your CGM export supplies variability and postprandial pattern; and an independent provider reads them against each other and your goals — rather than defaulting to "just exercise more."

On peptides and recovery specifically: some agents in that space are compounded rather than commercially manufactured. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Whether anything is appropriate — or prescribed at all — is a decision an independent licensed provider makes after reviewing your labs and history. A prescription is never guaranteed.

This article is educational and not medical advice. Use it to ask sharper questions, then let a qualified clinician interpret your specific data.

Where Velri fits

Velri is a technology and coordination company — not a medical practice. Velri can help coordinate lab collection, connect you with an independent, licensed provider who reviews your fasting panel alongside the CGM and wearable data you already track, and — only if that provider prescribes — coordinate fulfillment through an independent licensed pharmacy. The clinical judgment stays with the provider; Velri handles the logistics so your optimization work is lab-informed instead of guesswork.